Cyanidin 3-Rutinoside, an Anthocyanin Pigment of Schisandra chinensis Baill, Inhibits Allergic Inflammation
Autor: | Aye Aye, Jong-Sik Jin, Yun-Hoe Kim, Yong-Deok Jeon, Young-Jae Song, Ju-Ryoun Soh |
---|---|
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
030109 nutrition & dietetics Nutrition and Dietetics Antioxidant biology Chemistry Schisandra chinensis medicine.medical_treatment Cyanidin Medicine (miscellaneous) Pharmacology biology.organism_classification In vitro Allergic inflammation Proinflammatory cytokine 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine 030220 oncology & carcinogenesis Anthocyanin medicine Tumor necrosis factor alpha |
Zdroj: | Journal of Medicinal Food. 22:703-712 |
ISSN: | 1557-7600 1096-620X |
DOI: | 10.1089/jmf.2018.4346 |
Popis: | The occurrence of allergy-mediated inflammatory diseases such as asthma and atopic dermatitis have increased, but comprehensive treatment remains difficult. Previous studies have shown that Schisandra chinensis Baill has antioxidant, antidiabetic, and antitumorigenic effects. Cyanidin 3-rutinoside (CR) is the major anthocyanin pigment of S. chinensis. However, the biological effects of CR have been rarely studied to date. Therefore, the aim of this study was to investigate the regulatory effects of CR on phorbol-12-myristate-13-acetate (PMA)/A23187-induced allergic inflammation in vitro. CR inhibited the secretion of inflammatory cytokines such as interleukin-6 and tumor necrosis factor-α, and it also suppressed the phosphorylation of nuclear factor-kappa B. These results show that CR ameliorated PMA/A23187-induced allergic inflammation via the suppression of inflammatory cytokines in HMC-1 cells. Therefore, CR has potential as a therapeutic agent for allergic diseases. |
Databáze: | OpenAIRE |
Externí odkaz: |